# India Metabolomics Services Market

> India Metabolomics Services Market Research Report By Product Type (Chromatography, Metabolomics Bioinformatics Services, Mass Spectrometry) and By Application (Biomedical and Pharmaceutical, Agriculture, Food) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.74%
- **2024:** $ 16.07 Million
- **2025:** $ 17.31 Million
- **2035:** $ 36.5 Million
- **Key Players:** Metabolon (US), Biocrates Life Sciences (AT), Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), PerkinElmer (US), Sierra Analytics (US), Creative Proteomics (US)

**Report ID:** MRFR/HC/47909-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-metabolomics-services-market-49663

---

## Market Summary

## **India Metabolomics Services Market Overview**

As per MRFR analysis, the India Metabolomics Services Market Size was estimated at 131 (USD Million) in 2023. The India Metabolomics Services Market Industry is expected to grow from 147(USD Million) in 2024 to 788 (USD Million) by 2035. The India Metabolomics Services Market CAGR (growth rate) is expected to be around 16.491% during the forecast period (2025 - 2035)

**Key India Metabolomics Services Market Trends Highlighted**

The India Metabolomics Services Market is witnessing a notable shift towards personalizing medicine and diagnostics, driven by an increased focus on precision health. The rise of chronic diseases and genetic disorders in the country has boosted the demand for advanced diagnostic techniques, where metabolomics plays a pivotal role in understanding individual metabolic profiles. 

Additionally, the Indian government's initiatives toward advancing healthcare research and biotechnology, such as funding projects under the Biotechnology Industry Research Assistance Council (BIRAC), further bolster market growth. 

The integration of metabolomics into the pharmaceutical sector for drug development and discovery highlights another key driver, as companies are exploring innovative applications to streamline the drug development pipeline.Opportunities to be captured include collaborations between academic institutions and biotechnology firms, enhancing research capabilities to explore new applications in areas such as biomarker discovery and nutritional science. 

With India's diverse population, there is potential for developing tailored metabolomics tests that cater to various demographics, thereby facilitating a more personalized approach to health care. Furthermore, local startups are emerging in the field, promoting innovation and creating an ecosystem that supports new metabolomic technologies. 

Recent trends show an increase in workshops and training programs aimed at developing a skilled workforce familiar with metabolomics techniques.Moreover, the digitization of healthcare in India, with initiatives like the National Digital Health Mission, paves the way for better data integration and analysis, allowing for improved metabolomics applications. Overall, with the growing interest in lifestyle diseases and preventive health strategies, the metabolomics services market in India is poised for dynamic growth and development.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**India Metabolomics Services Market Drivers**

**Increasing Prevalence of Chronic Diseases**

India's growing prevalence of chronic illnesses, including diabetes, heart disease, and cancer, is a major factor propelling the India metabolomics services market. An estimated 8–10 million new instances of cancer are identified in India each year, and one in nine people is predicted to have cancer at some point in their lives, according to the Indian Council of Medical Research. This concerning figure highlights the need for cutting-edge diagnostic technologies like metabolomics, which improve our comprehension of illness causes and enable the development of individualized treatment regimens. 

The market's demand for services is being increased by well-known institutions like the Apollo Hospitals and the Tata Memorial Hospital actively working with research institutes to carry out metabolomics investigations. In India, the importance of metabolomics in disease management is growing due to the country's high-risk population and rise in lifestyle-related illnesses.

**Growth in Research and Development Initiatives**

There is a growing emphasis on Research and Development (R&D) initiatives aimed at exploring metabolomics applications in India. The Government of India's 'Make in India' initiative and the recent 'National Biotechnology Development Strategy 2021-2025' have allocated substantial funding towards biosciences and healthcare innovation. As a result, academic institutions and biotech firms are investing in metabolomics research, which is crucial for drug development and biomarker discovery.

Organizations like the Indian Institute of Science and Biocon are at the forefront of these efforts, conducting studies that advance the metabolomics field. This collaborative environment not only augments the Indian Metabolomics Services Market Industry but also aligns with global trends, enhancing the global competitiveness of Indian researchers.

**Increasing Adoption of Personalized Medicine**

The trend toward personalized medicine is reshaping healthcare in India, which profoundly affects the India Metabolomics Services Market Industry. As healthcare providers increasingly recognize that genetic and metabolic profiles influence treatment efficacy, there has been a surge in demand for metabolomics services that help tailor therapies to individual patient needs. 

The Indian Ministry of Health and Family Welfare has prioritized initiatives promoting personalized medicine, predicting that by 2025, approximately 75% of medical decisions will be guided by personalized approaches.Additionally, organizations like Reliance Life Sciences and Dr. Reddy's Laboratories are actively participating in this trend with their own metabolomics research, effectively driving market growth.

**India Metabolomics Services Market Segment Insights**

**Metabolomics Services Market Product Type Insights**

The India Metabolomics Services Market is experiencing significant growth and encompasses various product types that cater to a wide range of applications in sectors such as healthcare, agriculture, and environmental sciences. Chromatography holds a crucial position within this segment, as it facilitates the separation and analysis of complex mixtures, assisting researchers and industries in attaining accurate metabolomic data. 

This technique is increasingly utilized in drug development and clinical diagnostics, driving its demand in the Indian market.Metabolomics Bioinformatics Services are also vital, as they enhance the analysis and interpretation of vast datasets generated from metabolomic studies, translating raw data into valuable biological insights. This area is increasingly recognized for its role in system biology and personalized medicine, leading to greater emphasis on its adoption in research institutions and healthcare settings in India. 

Meanwhile, Mass Spectrometry acts as a powerful tool for quantifying metabolites with high specificity and sensitivity, making it indispensable in clinical laboratories.Its ability to provide detailed molecular information gives it a competitive edge, particularly in applications related to biomarker discovery and disease profiling. The integration of these product types supports advancements in research and development, fostering collaboration among academic institutions, healthcare facilities, and private industry, all of which are crucial for the overall evolution of the India Metabolomics Services Market, driving innovation and enhancing the country's position in the global metabolomics landscape. 

As the market continues to grow, there are ample opportunities for new technologies and methodologies that can further streamline metabolomics research while enhancing overall outputs, addressing the increasing demand for efficient and accurate analytical solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Metabolomics Services Market Application Insights**

The Application segment of the India Metabolomics Services Market is witnessing substantial growth, driven by escalating demand across various sectors. The Biomedical and Pharmaceutical applications play a crucial role in enhancing drug development, personalized medicine, and understanding metabolic diseases, thereby significantly impacting healthcare outcomes. In agriculture, metabolomics contributes to crop improvement and pest resistance, allowing for enhanced food security in a nation heavily reliant on its agriculture sector. 

The Food industry leverages metabolomics for quality control and safety assurance, ensuring products meet health standards and consumer expectations.This fundamental role of metabolomics services in optimizing processes and driving innovations positions the Applications segment as a substantial contributor to the overall market dynamics. With an increasing focus on sustainability and health consciousness among consumers, these applications are positioned to meet emerging demands while fostering advancements across their respective fields. 

The integration of technologies and increased R&D investments, further bolstered by government initiatives, promote growth opportunities, showcasing the significance of this segment within the broader India Metabolomics Services Market landscape.

**India Metabolomics Services Market Key Players and Competitive Insights**

The India Metabolomics Services Market is witnessing notable growth driven by an increasing demand for personalized medicine, advancements in diagnostic technologies, and a growing understanding of the roles that metabolites play in health and disease. The competitive landscape is characterized by diverse players, ranging from established biotechnology firms to emerging start-ups, each striving to differentiate themselves through innovative services and cutting-edge technologies. These companies are keenly focused on expanding their capabilities to offer high-quality metabolic profiling services, enhancing their market presence, and fostering strategic alliances to bolster their service offerings and reach within the Indian healthcare ecosystem.

Biocrates Life Sciences has made significant inroads within the India Metabolomics Services Market by providing advanced targeted metabolomics solutions that cater to various research and clinical applications. The company is recognized for its high-quality products and comprehensive service offerings that include the examination of metabolic profiles for disease diagnosis and research purposes. One of the pivotal strengths of Biocrates Life Sciences is its cutting-edge technology that ensures precise and reliable data, making it a preferred choice among Indian research institutions and clinical laboratories. 

Additionally, the company's commitment to generating impactful research insights positions it favorably in a rapidly evolving market, allowing it to maintain a competitive edge.SciMed, operating within the India Metabolomics Services Market, stands out due to its diverse range of key products and services aimed at metabolomic analysis. The company has garnered attention for its innovative approach, focusing on high-throughput analysis to meet the demands of researchers and clinicians. SciMed’s strengths lie in its robust networking within the Indian biotechnology sphere and its ability to provide tailored services that address the unique needs of the local market. 

Furthermore, the company has engaged in strategic partnerships and collaborations, enhancing its capabilities while keeping pace with emerging trends in metabolomics. Through these avenues, SciMed is actively contributing to the advancement of metabolomic research in India, thereby solidifying its market presence and fostering growth.

**Key Companies in the India Metabolomics Services Market Include**

**India Metabolomics Services Market Industry Developments**

The India Metabolomics Services Market is witnessing significant advancements and developments. The increasing demand for personalized medicine and biomarker discovery is propelling growth in this sector. Notably, Biocrates Life Sciences and Metabolon have been expanding their service offerings in metabolomics analysis to cater to the burgeoning biopharmaceutical sector. In August 2023, Thermo Fisher Scientific announced the launch of its new high-resolution mass spectrometer aimed at enhancing metabolomics research capacity in India. 

Additionally, Agilent Technologies has been focusing on providing tailored solutions for Indian researchers, thereby increasing its market footprint. Significant mergers and acquisitions have also been observed; for instance, in June 2023, PerkinElmer acquired a leading Indian metabolomics company to bolster its analytics services. The Indian government is also fostering a conducive environment for biotechnology firms through initiatives aimed at encouraging Research and Development, and innovation in healthcare.

Over the past two years, the market has shown a solid growth trajectory, driven by an increase in research funding and collaborations among academic and research institutions, underscoring the critical role of metabolomics in advancing health sciences in India.

**India Metabolomics Services Market Segmentation Insights**

## Market Drivers

### Growing Research Funding

The increasing allocation of research funding in India is a pivotal driver for the metabolomics services market. Government initiatives and private sector investments are enhancing the financial resources available for scientific research. In recent years, funding for life sciences research has seen a notable rise, with allocations reaching approximately $1 billion in 2025. This influx of capital is likely to facilitate the development of advanced metabolomics technologies and services. Furthermore, the emphasis on health and disease prevention is steering research towards metabolomics, as it offers insights into metabolic pathways and disease mechanisms. Consequently, the growth in research funding is expected to bolster the metabolomics services market, enabling the establishment of state-of-the-art laboratories and fostering innovation in analytical methodologies.

### Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases in India is significantly influencing the metabolomics services market. With conditions such as diabetes, cardiovascular diseases, and cancer becoming more prevalent, there is a pressing need for advanced diagnostic and therapeutic solutions. Metabolomics provides a comprehensive approach to understanding disease mechanisms and identifying biomarkers for early detection. Reports indicate that chronic diseases account for nearly 60% of all deaths in India, underscoring the urgency for effective management strategies. As healthcare providers seek to implement personalized treatment plans, the demand for metabolomics services is expected to surge. This trend not only highlights the importance of metabolomics in clinical settings but also positions it as a critical component in the broader healthcare landscape.

### Rising Awareness of Preventive Healthcare

There is a growing awareness of preventive healthcare among the Indian population, which is driving the metabolomics services market. As individuals become more health-conscious, there is an increasing demand for services that can provide insights into metabolic health and disease risk. Metabolomics plays a crucial role in preventive healthcare by identifying biomarkers that can indicate potential health issues before they manifest. This proactive approach is gaining traction, particularly among urban populations, where lifestyle-related diseases are on the rise. The market for preventive healthcare services is anticipated to grow by approximately 15% annually, indicating a robust opportunity for metabolomics services to cater to this emerging demand. As healthcare providers integrate metabolomics into routine health assessments, the market is likely to experience substantial growth.

### Technological Advancements in Metabolomics

Technological innovations are propelling the growth of the metabolomics services market in India. The advent of high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy has revolutionized the analysis of metabolites, allowing for more precise and comprehensive profiling. These advancements enable researchers and clinicians to obtain detailed metabolic information, which is crucial for understanding complex biological systems. The market for analytical instruments in India is projected to grow at a CAGR of 10% through 2025, reflecting the increasing adoption of sophisticated technologies in metabolomics. As laboratories invest in cutting-edge equipment, the quality and reliability of metabolomics services are expected to improve, thereby attracting more clients and expanding the market.

### Collaboration Between Healthcare and Research Institutions

The collaboration between healthcare providers and research institutions is fostering growth in the metabolomics services market. Such partnerships facilitate the translation of research findings into clinical applications, enhancing the relevance and utility of metabolomics in healthcare. In India, several initiatives are underway to bridge the gap between academia and industry, promoting the sharing of knowledge and resources. These collaborations are expected to lead to the development of innovative metabolomics applications, particularly in personalized medicine and drug discovery. As research institutions and healthcare providers work together, the metabolomics services market is likely to benefit from increased access to cutting-edge research and technology, ultimately improving service offerings and patient outcomes.

## Future Outlook

The [Metabolomics Services Market](https://www.marketresearchfuture.com/reports/metabolomics-services-market-8435) is projected to grow at a 7.74% CAGR from 2025 to 2035, driven by advancements in technology, increasing research funding, and rising demand for personalized medicine.

**New opportunities:**

- Development of integrated metabolomics platforms for clinical diagnostics.
- Expansion of metabolomics applications in agricultural biotechnology.
- Partnerships with pharmaceutical companies for drug discovery and development.

By 2035, the metabolomics services market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product and Service: Chromatography (Largest) vs. Mass Spectrometry (Fastest-Growing)

In the India metabolomics services market, the product and service segment displays a dynamic distribution among chromatography, metabolomics bioinformatics services, and mass spectrometry. Chromatography accounts for the largest share, primarily due to its widespread applications in separation techniques across various industries. Meanwhile, mass spectrometry, while occupying a smaller market share, is recognized as the fastest-growing segment, driven by advancements in technology and increasing adoption in research and clinical laboratories.

The growth trends indicate a robust trajectory for the metabolomics bioinformatics services, spurred by the rising demand for data analysis capabilities in metabolomics research. Additionally, the integration of AI and machine learning in bioinformatics is propelling innovations, thus fostering the expansion of the market. As organizations increasingly rely on precise metabolic profiling, the intersection of technology and service offerings will be critical for future growth.

Chromatography: Dominant vs. Mass Spectrometry: Emerging

Chromatography holds a dominant position in the India metabolomics services market, recognized for its reliability and efficiency in analyzing complex mixtures. It serves vital functions in various applications, from quality control in pharmaceuticals to food safety, fulfilling essential roles in regulatory compliance. In contrast, mass spectrometry is an emerging player, rapidly gaining traction due to its sensitivity and capability to analyze a broad range of biomolecules. The surge in R&D activities and its growing application in clinical diagnostics and personalized medicine signal a bright future for mass spectrometry, positioning it strategically for significant market growth.

### By Application: Biomedical and Pharmaceutical (Largest) vs. Food (Fastest-Growing)

The application segment of the India metabolomics services market showcases a diverse landscape with significant contributions from Biomedical and Pharmaceutical sectors, which currently hold the largest market share. This dominance is attributed to the increasing demand for drug development and personalized medicine initiatives. Conversely, the Food sector is emerging rapidly, capturing attention due to rising consumer awareness about nutrition and health. This shift reflects changing dietary preferences and the growing trend of food safety and quality testing.

Growth trends indicate a robust expansion in both sectors, primarily driven by technological advancements and research breakthroughs. The Biomedical and Pharmaceutical applications are propelled by innovative biotechnologies and regulatory support, enhancing efficiencies in drug discovery processes. Meanwhile, the Food application is flourishing due to heightened interest from stakeholders in health-focused initiatives, including functional foods and nutraceuticals, furthering its position as the fastest-growing segment.

Biomedical and Pharmaceutical (Dominant) vs. Food (Emerging)

The Biomedical and Pharmaceutical application within the India metabolomics services market is characterized by its robust market position, driven by extensive R&D efforts and substantial investments in health sciences. This sector plays a crucial role in advancing drug discovery, enabling researchers to comprehensively understand disease mechanisms through metabolic profiling. In contrast, the Food application, while currently emerging, is gaining traction fueled by consumer trends prioritizing health and wellness. This segment engages in thorough food analysis and quality assessment, reflecting the growing demand for transparency in food supply chains. Both sectors underscore the importance of metabolomics in enhancing health outcomes and ensuring product safety, underscoring their vital roles in the overall market.

## Competitive Benchmarking

The metabolomics services market in India is characterized by a dynamic competitive landscape, driven by advancements in analytical technologies and an increasing focus on personalized medicine. Key players such as Metabolon (US), Agilent Technologies (US), and Thermo Fisher Scientific (US) are at the forefront, leveraging their extensive expertise in metabolomics to enhance service offerings. Metabolon (US) emphasizes innovation in biomarker discovery, while Agilent Technologies (US) focuses on expanding its product portfolio through strategic partnerships. Thermo Fisher Scientific (US) is enhancing its market presence by investing in digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological advancements and strategic collaborations.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance service delivery. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they set industry standards and drive innovation. This competitive structure fosters an environment where smaller firms may struggle to keep pace with the rapid advancements and resource capabilities of larger entities.

In October  Metabolon (US) announced a collaboration with a leading Indian research institution to develop novel metabolomic biomarkers for chronic diseases. This strategic move is likely to enhance Metabolon's research capabilities and expand its footprint in the Indian market, aligning with the growing demand for personalized healthcare solutions. Such collaborations not only bolster Metabolon's service offerings but also position it as a key player in the burgeoning Indian healthcare landscape.

In September  Agilent Technologies (US) launched a new suite of metabolomics tools tailored for the Indian market, aimed at improving the efficiency of metabolic profiling. This launch is significant as it reflects Agilent's commitment to addressing local market needs and enhancing its competitive edge through innovation. By providing advanced tools that cater specifically to regional requirements, Agilent is likely to strengthen its market position and attract a broader customer base.

In August  Thermo Fisher Scientific (US) expanded its service capabilities by acquiring a local metabolomics service provider in India. This acquisition is indicative of Thermo Fisher's strategy to enhance its operational footprint and service offerings in the region. By integrating local expertise, the company is poised to deliver more tailored solutions, thereby increasing its competitiveness in the Indian metabolomics services market.

As of November  current trends in the metabolomics services market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in analytical processes. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on innovation and technology rather than price-based competition. Companies that can reliably integrate advanced technologies into their service offerings are likely to gain a competitive advantage, ensuring their relevance in a rapidly changing market.

## Recent News & Developments

The India Metabolomics Services Market is witnessing significant advancements and developments. The increasing demand for personalized medicine and biomarker discovery is propelling growth in this sector. Notably, Biocrates Life Sciences and Metabolon have been expanding their service offerings in metabolomics analysis to cater to the burgeoning biopharmaceutical sector. In August 2023, Thermo Fisher Scientific announced the launch of its new high-resolution mass spectrometer aimed at enhancing metabolomics research capacity in India. 

Additionally, Agilent Technologies has been focusing on providing tailored solutions for Indian researchers, thereby increasing its market footprint. Significant mergers and acquisitions have also been observed; for instance, in June 2023, PerkinElmer acquired a leading Indian metabolomics company to bolster its analytics services. The Indian government is also fostering a conducive environment for biotechnology firms through initiatives aimed at encouraging Research and Development, and innovation in healthcare.

Over the past two years, the market has shown a solid growth trajectory, driven by an increase in research funding and collaborations among academic and research institutions, underscoring the critical role of metabolomics in advancing health sciences in India.

## Report Scope

| MARKET SIZE 2024 | 16.07(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 17.31(USD Million) |
| MARKET SIZE 2035 | 36.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.74% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Metabolon (US), Biocrates Life Sciences (AT), Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), PerkinElmer (US), Sierra Analytics (US), Creative Proteomics (US) |
| Segments Covered | Product and Service, Application |
| Key Market Opportunities | Advancements in personalized medicine drive demand for innovative metabolomics services market solutions. |
| Key Market Dynamics | Rising demand for personalized medicine drives growth in metabolomics services, influencing competitive dynamics and technological advancements. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What was the market valuation of the India metabolomics services market in 2024?**
A: The market valuation was $16.07 Million in 2024.

**Q: What is the projected market valuation for the India metabolomics services market by 2035?**
A: The projected valuation for 2035 is $36.5 Million.

**Q: What is the expected CAGR for the India metabolomics services market during the forecast period 2025 - 2035?**
A: The expected CAGR is 7.74% during the forecast period 2025 - 2035.

**Q: Which segments contributed to the India metabolomics services market in 2024?**
A: Key segments included Chromatography at $5.0 Million, Metabolomics Bioinformatics Services at $4.0 Million, and Mass Spectrometry at $7.07 Million.

**Q: What applications are driving the India metabolomics services market?**
A: The primary applications are Biomedical and Pharmaceutical at $6.42 Million, Agriculture at $4.82 Million, and Food at $4.83 Million.

**Q: Who are the key players in the India metabolomics services market?**
A: Key players include Metabolon, Biocrates Life Sciences, Agilent Technologies, and Thermo Fisher Scientific.

**Q: How does the market for Mass Spectrometry compare to other segments in 2024?**
A: Mass Spectrometry was valued at $7.07 Million, indicating a strong position compared to other segments.

**Q: What growth trends are anticipated for the Agriculture application in the India metabolomics services market?**
A: The Agriculture application is projected to grow from $4.82 Million in 2024 to $10.5 Million by 2035.

**Q: What is the significance of metabolomics bioinformatics services in the market?**
A: Metabolomics Bioinformatics Services were valued at $4.0 Million in 2024, suggesting a growing importance in data analysis.

**Q: How do the projected growth figures for the India metabolomics services market reflect industry trends?**
A: The projected growth from $16.07 Million in 2024 to $36.5 Million by 2035 indicates a robust expansion in the sector.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-metabolomics-services-market-49663*